References

Cases

cancer
A large international pharmaceutical company will apply for the Class 1 reimbursement of a novel therapy, CAR-T, to treat patients with diffuse large B-cell lymphoma (DLBCL). The customer has asked...
CAR T-cell therapy
A large international pharmaceutical company will apply for the Class 1 reimbursement of a novel therapy, CAR-T, to treat patients with paediatric acute lymphoblastic leukaemia (pALL).  The...
Patiënt blood management in België
Patient blood management (PBM) becomes increasingly important for hospitals, as policies and guidelines are developed. The European Commission recently published a practical implementation guide for...

Our clients

Abbott Diagnostics
Belgium & UK
Abbvie
Belgium
Adinfo
Belgium
Agfa Healthcare nv
Belgium
Al-Ahli Hospital
Qatar
Amgen
Europe
AstraZeneca
Belgium
AZ Damiaan, Oostende
Belgium
AZ Glorieux
Belgium
AZ Heilige Familie Rumst
Belgium
AZ Jan Portaels
Belgium
AZ Maria Middelares
België
AZ Nikolaas
Belgium
AZ Sint-Augustinus Veurne
Belgium
AZ Sint-Blasius
Belgium
Ezelstraat 69 | B- 8000 Brugge | Belgium | Phone: +32.50.33.33.40 | Fax: +32.50.33.33.39 | BTW BE 0866 039 556 | RPR/RPM Brugge | e-mail: info@hict.com